However, KM curves and log-rank tests revealed that high expression of tumor PD-L2 was associated with a remarkably longer 5-year OS than low expression of tumor PD-L2 in advanced stage patients (57% vs 40%, p < 0.001, Fig. 1G). Here, PDCD1LG2 is linked to neoplasm.